• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Only one Day left: DUPHAT 2024 is set to kick off tomorrow
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Health Conferences & Events | ุงู„ู…ุคุชู…ุฑุงุช ูˆุงู„ูุนุงู„ูŠุงุช ุงู„ุตุญูŠุฉ > Only one Day left: DUPHAT 2024 is set to kick off tomorrow
Health Conferences & Events | ุงู„ู…ุคุชู…ุฑุงุช ูˆุงู„ูุนุงู„ูŠุงุช ุงู„ุตุญูŠุฉLeadNews

Only one Day left: DUPHAT 2024 is set to kick off tomorrow

ME Desk
ME Desk
Published: January 8, 2024
Share
4 Min Read
Only one Day left: DUPHAT 2024 is set to kick off tomorrow
SHARE

Dubai, UAE- January 2024- The largest-ever Dubai International Pharmaceutical Technologies Conference and Exhibition, or DUPHAT 2024, will take place at the Dubai World Trade Center starting on January 9. This event, recognized as the largest pharmaceutical gathering in the Middle East and Africa, anticipates over 32,000 attendees.

Contents
  • Why to participate in DUPHAT 2024
        • H.E. Amb. Dr. Abdulsalam AlMadani, Executive Chairman of DUPHAT, emphasized, โ€œDUPHAT 2024 continues its unwavering commitment to promoting the highest standards in the pharmaceutical industry through quality products and innovative technology. This year marks significant accomplishments as DUPHAT 2024 reaches its grandest magnitude in history, reinforcing the value of this profound event.โ€

With 28 successful editions, DUPHAT has become a global platform, bringing together professionals in the pharmaceutical and manufacturing sectors. It serves as a showcase for leading pharmaceutical suppliers, highlighting innovative products and solutions, while promoting the exchange of information, ideas, and breakthroughs in pharmacy, technology, medicines, and patient care.

Why to participate in DUPHAT 2024

By 2025, experts anticipate that the United Arab Emiratesโ€™ pharmaceutical market will surpass USD 4.7 billion, marking a substantial 27% growth over the preceding five years. The UAE, producing over 2,500 medications, stands as a symbol of dedication and robust manufacturing capabilities. It is anticipated that the MENA pharmaceutical market will surpass USD 50 billion globally, thereby establishing the regionโ€™s dominance in the global pharmaceutical arena. More than just a single event, DUPHAT 2024 is an exciting journey that will shape healthcare in the future for a better and healthier tomorrow by fusing innovation and knowledge.

DUPHAT 2024 will host a multinational environment with representatives from 95 countries, featuring 150 speakers delivering 120 lectures and overseeing 16 workshops. The event will also welcome university students, presenting 350 posters showcasing the latest medical research and breakthroughs. The exhibition and conference offer multiple workshops, and a Pharma business hub running concurrently. Attendees can earn 63 CME hours accredited by the Dubai Health Authority, and 22 CPD credits from the Society of Hospital Pharmacists of Australia.

H.E. Amb. Dr. Abdulsalam AlMadani, Executive Chairman of DUPHAT, emphasized, โ€œDUPHAT 2024 continues its unwavering commitment to promoting the highest standards in the pharmaceutical industry through quality products and innovative technology. This year marks significant accomplishments as DUPHAT 2024 reaches its grandest magnitude in history, reinforcing the value of this profound event.โ€

Dr. Ali Al Sayed Hussain, Chairman of DUPHAT, stated: โ€œDUPHAT aspires to stand as the quintessential platform for pharmacists, industry professionals, marketing experts, academicians, researchers, scientists, students, and affiliated healthcare professionals to engage in meaningful interactions, fostering the exchange of knowledge and expertiseโ€™โ€™.

Moreover, The DUPHAT conference and exhibition offer pharmaceutical companies an opportunity to launch new products, stay abreast of technological advancements, acquire scientific knowledge, network with industry peers, exchange expertise with specialists, and explore solutions to industry challenges. Dedicated sessions will also address the proper use of โ€˜over-the-counter products,โ€™ reflecting the significant awareness and growth observed in recent years.

Also Read: Arab Health 2024 Breaks Records: All Set to flabbergast the World with Healthcare Innovations

DUPHAT is organized annually by INDEX Conferences and Exhibitions โ€“ a member of INDEX Holding. It receives support from Dubai Health Authority, American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia, and the European Society of Oncology Pharmacy.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Did Medtronic Attain CE Mark? Did Medtronic Attain CE Mark for Its Latest Micra Leadless Pacing Systems?
Next Article https://mededgemea.com/abbotts-strategic-partnership-with-mabxience-boosts-access-to-oncology-and-womens-health-biosimilars-in-emerging-markets/ Mark Your Calendar: Abbott Q4 Earnings Call Coming Soon?

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Only one Day left: DUPHAT 2024 is set to kick off tomorrow
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Only one Day left: DUPHAT 2024 is set to kick off tomorrow
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?